Forschung

• Literatur

• 1 Richter C, Pausch G, Barczyk S, Priegnitz M, Keitz I, Thiele J, Smeets J, Vander Stappen F, Bombelli L, Fiorini C, Hotoiu L, Perali I, Prieels D, Enghardt W, Baumann M. First clinical application of a prompt gamma based in vivo proton range verification system. Radiother Oncol 2016; 118(2): 232-7 Epub 2016 Jan 13
• 2 Maurer T, Schwamborn K, Schottelius M, Wester H-J, Schwaiger M, Gschwend J, Eiber M. PSMA THeranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer. Journal of Clinical Genitourinary Cancer 2016;
• 3 Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester H-J, Gschwend J, Eiber M. Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer. European Urology 2015;
• 4 Eiber M, Maurer T, Souvatzoglou M, Beer A, Ruffani A, Haller B, Graner F-P, Kübler H, Haberhorn U, Eisenhut M, Wester H-J, Gschwend J, Schwaiger M. Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy. Journal of Nuclear Medicine 2015;